CMV Research Awards
At National CMV, we fund research and work to influence research priorities regarding CMV prevention, treatment, and intervention. Learn more about our grant opportunities below.
Early Career Congenital CMV Research Award
In its fourth year, the National CMV Foundation is pleased to fund innovative research related to maternal or congenital cytomegalovirus (CMV) infections. These awards are made possible by individual, charitable contributions to the National CMV Foundation in support of research that will lead to the elimination of disabilities due to congenital CMV infection.
Award
The National CMV Foundation (NCMVF) Early Career Congenital CMV Research Award is a $50,000 award to fund innovative research related to maternal or congenital CMV infections. Preference will be given to projects in areas including, but not limited to, health services implementation, proof of concept or program evaluation, CMV disparities, public health messaging, prevention, treatment, or outcomes.
Eligibility
Early career researchers including mentored pre- and post-doctoral trainees or junior faculty members who have not been a principal investigator (PI) on a National Institutes of Health (NIH) grant may apply for the award. Trainee applicants must provide a letter of support and a mentoring plan from the Mentor. Applications will be accepted from researchers in the United States and Canada.
Terms
- Grant Title: Early Career Congenital CMV Research Award
- Selection Method: Competitive Bid
- Number of Awards: One
- Award Amount: $50,000
- Award Period: 12 or 24-months; non-renewable. Maximum of one-year no-cost extension allowable, contingent on approval from National CMV's Scientific Advisory Committee.
- Use of Funds: A detailed budget and budget justification constitute part of the application and will be evaluated as part of the review process. Funding may not be used for travel or to support the PI's salary during the period of the award. Award funds are designated for direct costs only and do not include an indirect cost component. Unexpended funds will be returned to the National CMV Foundation.
- Institutions: Award may be made for not-for-profit organizations (e.g. hospitals, universities, national charities and/or foundations).
- Issuing Agency: National CMV Foundation, PO BOX 18322, Tampa, FL 33679
Application Process
Applications for awards must be submitted electronically to
grants@nationalcmv.org by 11:59pm EST on May 31, 2022. Late applications will not be considered. Applications must comply with the standardized format described below. The NCMVF Scientific Advisory Committee will review applications and make a funding recommendation to the Foundation’s board of directors for final approval.
Review Timeline
- 11:59pm EST May 31, 2022 -- Award applications due
- July 15, 2022 -- Reviews complete
- July 22, 2022 -- Award recipient announced
- August 1, 2022 -- Funding available
Review Process
All acceptable applications will be peer reviewed by outside expert reviewers and the NCMVF Scientific Advisory Committee. The review process will follow that of the NIH, whereby there will be a primary and two secondary reviewers. Formal reviews will be written on each application and the critique returned to the investigator within a reasonable period after the completion of the review process. Applications will be evaluated according to the NIH scoring system. Each application will be evaluated for Significance, Innovation, Approach, Investigator and Overall.
The NCMVF Scientific Advisory Committee will review all applications prior to making funding decisions and will review all applications for consistency of the peer review. Committee members will not review applications from collaborators or students.
Application Format
Applications are in a similar format to the NIH. All applications must be completed and submitted to
grants@nationalcmv.org.
1.Face Page (use attached form)
2.Project Summary, Relevance, Suggested Reviewers, Key Personnel (1 page)
3.Specific Aims (1/2 page)
4.Research Strategy (3 ½ pages)
5.Budget for Year One with Justification
6.Applicant biographical Sketch(es) (use attached from)
7.Human Subjects or Vertebrate Animals approval
8.Literature Cited
9.Letter(s) from Collaborators (as applicable)
10.Letter of Support from Mentor (required for trainee investigators) including a detailed mentoring plan. The mentoring plan should include the mentor’s CV, including [detail relevant methodologic and/or career experience and be committed to supporting the applicant].
If the proposed research involves human subjects or vertebrate animals at any time, the project must be reviewed and approved by the appropriate Institutional Review Board (IRB) or Animal Care and Use Committee (IACUC). This approval should be obtained prior to submission if possible and submitted with the application. If such approval is unavoidably delayed, enter “pending” instead of the approval date on the face page. NCMVF will not release any monies until all appropriate approvals have been obtained.
Reporting Requirements
Recipients of the National CMV Foundation Early Career Congenital CMV Research Award are required to complete an interim progress report at 6 months for 12-month awards, and 12 months for 24-month awards. Within 90 days of the completion of the project, the awardee must submit a final report. A final financial report must be submitted within 90 days of the close of the project. Any publications resulting from a project supported with the award shall acknowledge the contribution of the National CMV Foundation.
For Download
Learn more about our previous recipients and their proposed studies at the links below.
2020
Jennifer Jenks, M.D., PhD Candidate, Duke University
Fatima Kakkar, M.D., MPH, CHU Sainte-Justine
Megan Pesch, M.D., University of Michigan
2019
Swetha Pinninti, M.D. University of Alabama Birmingham
Maria Talavera, DO Nationwide Children's Hospital
2018
Paul Lantos, M.D. Duke University
Pediatric Infectious Disease Society (PIDS) CMV Fellowship Award for CMV Research
The
PIDS Fellowship Award for CMV Research, established by the National CMV Foundation, will specifically fund Pediatric Infectious Disease basic or clinical research focused on congenital cytomegalovirus (CMV). This award is a two-year award at $25,000 per year (inclusive of 8% indirect costs), with renewal in the second-year dependent upon satisfactory research progress, for trainees with an MD, PhD, or MD-PhD degree. All applicants must have a mentor (primary or co-supervisor) who is an active PIDS member, and the award may be used at the discretion of the applicant, including salary support, purchase of small equipment, technical support, or research supplies. One award is available.
The 2020 award period is now closed; recipient to be announced on October 20th!
Learn more about our 2017 recipient,
Dr. Frances Saccoccio from Duke University Medical Center, and her
completed study!